Fresenius Medical Care AGXTER:FME +0.73%70 Operating Margin % is 8.14% as of Mar. 2026, which is 29% below its 10-year median of 11.46. GuruFocus rates XTER:FME with a GF Score™ of 70/100 and a GF Value™ of €41.29 (Fairly Valued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 67.22% on this metric.
Fresenius Medical Care AG operating margin has been in a 5-year decline. The average rate of decline per year is -6.6%.
The historical rank and industry rank for Fresenius Medical Care AG's Operating Margin % or its related term are showing as below:
XTER:FME'
s Operating Margin % Range Over the Past 10 Years
Min: 7.5 Med: 11.46 Max: 14.1
Current: 9.41
XTER:FME's Operating Margin % is ranked better than 67.22% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs XTER:FME: 9.41
Fresenius Medical Care AG (XTER:FME) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Fresenius Medical Care AG Operating Margin % Related Terms
Fresenius Medical Care AG Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG Operating Margin % Chart
XTER:FME vs HCA, THC, DVA: Operating Margin % Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's Operating Margin % falls into.
Fresenius Medical Care AG Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Fresenius Medical Care AG's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (XTER:FME) has a Operating Margin % of 8.14% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Fresenius Medical Care AG and its competitors. This is 29% below median its historical median of 11.46. Over the past decade, Fresenius Medical Care AG's Operating Margin % has ranged from 7.50 to 14.10. According to the industry distribution chart, Fresenius Medical Care AG ranks #219 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 32.8%.
Is Fresenius Medical Care AG's Operating Margin % too high?
Fresenius Medical Care AG's current Operating Margin % of 8.14% is 29% below median its 10-year median of 11.46. Over the past 10 years, this metric has ranged from a low of 7.50 to a high of 14.10. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Fresenius Medical Care AG's value of 8.14% is 68% above this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #219 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #219 out of 668 companies for Operating Margin %. This puts Fresenius Medical Care AG in the upper half of its industry. The industry median Operating Margin % is 4.85. Fresenius Medical Care AG's value of 8.14% is 68% above this benchmark. Historically, Fresenius Medical Care AG's own Operating Margin % has ranged from 7.50 to 14.10 over the past decade. While the company's 10-year median is 11.46 vs. the industry median of 4.85, Fresenius Medical Care AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Operating Margin % of 8.14% is 68% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Operating Margin % is 8.14%, which is 29% below median its own 10-year median of 11.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (XTER:FME) is currently considered Fairly Valued. The stock's GF Value™ is €41.29, compared to a current price of €41.55 — trading 0.6% above its estimated fair value. The current Operating Margin % is 8.14%, which is 29% below median its 10-year median of 11.46 and 68% above the Healthcare Providers & Services industry median of 4.85. Fresenius Medical Care AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Fresenius Medical Care AG (XTER:FME), the current Operating Margin % is 8.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (XTER:FME) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued.
The current stock price of €41.55 is trading 0.6% above its estimated GF Value™ of €41.29.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for XTER:FME:
Operating Margin %: 8.14% (29% below median its 10-year median of 11.46)
GF Value™: €41.29 vs. price of €41.55 (0.6% above fair value)
Industry Position: 68% above the Healthcare Providers & Services median (#219 of 668)
No single metric tells the full story. See the XTER:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
70GF Score
Get the complete analysis for XTER:FME
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:FME has been successfully added to your 
